Reference health

Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility

https://doi.org/10.1016/s0142-9612(03)00161-3
CiteStamped reference-health badge
137/137 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

13 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 137 checked references that resolve
resolves10.1016/S0039-6028(01)01587-4
Biomedical surface science: Foundations to frontiers
resolves10.1016/S0168-3659(98)00178-3
Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems
resolves10.1016/S0168-3659(01)00502-8
Reducing capsular thickness and enhancing angiogenesis around implant drug release systems
resolves10.1016/0923-1137(94)00097-O
Polymer science for macroencapsulation of cells for central nervous system transplantation
resolves10.1016/S0142-9612(00)00149-6
Biomaterial–microvasculature interactions
resolves10.1016/S0169-409X(00)00054-5
Immunocompatibility and biocompatibility of cell delivery systems
resolves10.1016/S0169-409X(98)00023-4
Host response to tissue engineered devices
resolves10.1007/BF01161439
Tissue-biomaterial interactions
resolves10.1016/S0169-409X(96)00404-8
Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers
resolves10.1038/75705
Cell replacement therapies for central nervous system disorders
resolves10.1016/S0168-3659(99)00229-1
Targeted drug delivery for brain cancer treatment
resolves10.1002/jbm.820280913
Fate and biocompatibility of three types of microspheres implanted into the brain
resolves10.1111/j.2042-7158.1998.tb06185.x
Polymeric Chitosan-based Vesicles for Drug Delivery
resolves10.1016/S1381-5148(00)00038-9
A review of chitin and chitosan applications
resolves10.1016/S0169-409X(01)00188-0
Modern drug delivery applications of chitosan
resolves10.1002/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I
A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats
resolves10.1016/S0142-9612(98)00049-0
In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films
resolves10.1016/0169-409X(95)00092-L
Biosynthetic polyhydroxyalkanoates and their potential in drug delivery
resolves10.1016/S0169-409X(01)00218-6
Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate
resolves10.1016/S0142-9612(01)00260-5
Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates
resolves10.1016/S0169-409X(97)00119-1
Protein release from collagen matrices
resolves10.1002/jbm.10060
Chemistry and biocompatibility of alginate‐PLL capsules for immunoprotection of mammalian cells
resolves10.1016/S0142-9612(98)00034-9
Sugar cross-linked gelatin for controlled release: microspheres and disks
resolves10.1016/S0378-5173(00)00681-5
Gelatin microspheres crosslinked with d,l-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies
resolves10.1615/CritRevTherDrugCarrierSyst.v15.i5.30
Hyaluronate Derivatives in Drug Delivery
resolves10.1016/S0378-5173(01)00912-7
Characterization of subcutaneous Contramid® implantation: host response and delivery of a potent analog of the growth hormone-releasing factor
resolves10.1016/S0142-9612(01)00272-1
The biocompatibility of novel starch-based polymers and composites: in vitro studies
resolves10.1016/S0169-409X(00)00122-8
Nanoparticulate systems for brain delivery of drugs
resolves10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
Does surface chemistry affect thrombogenicity of surface modified polymers?
resolves10.1016/S1359-0294(00)00046-7
Physicochemical aspects of drug delivery and release from polymer-based colloids
resolves10.1016/S0169-409X(02)00017-0
Block copolymer micelles for delivery of gene and related compounds
resolves10.1016/S0169-409X(02)00015-7
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
resolves10.1023/A:1007552007765
Biodegradable Polyester, Poly[α-(4-Aminobutyl)-l-Glycolic Acid], as a Non-Toxic Gene Carrier
resolves10.1016/S0168-3659(01)00459-X
α,β-poly(asparthylhydrazide)–glycidyltrimethylammonium chloride copolymers (PAHy–GTA): novel polymers with potential for DNA delivery
resolves10.1016/0167-5699(94)90137-6
The acute phase response
resolves10.1093/ajcp/103.4.466
Inflammatory Responses to Biomaterials
resolves10.1016/S0169-409X(97)00048-3
Biodegradation and biocompatibility of PLA and PLGA microspheres
resolves10.1163/156856298X00370
Mechanisms of fibrinogen domains : biomaterial interactions
resolves10.1016/0142-9612(92)90010-L
Immune response in biocompatibility
resolves10.1089/107632700320784
Viability of HEMA-MMA Microencapsulated Model Hepatoma Cells in Rats and the Host Response
resolves10.1016/S0169-409X(01)00244-7
ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins
resolves10.1016/S0022-510X(98)00049-5
Immune regulation within the central nervous system
resolves10.1016/S0165-5728(97)00006-4
Factors controlling T-cell migration across rat cerebral endothelium in vitro
resolves10.1002/glia.1101
Basic principles of immunological surveillance of the normal central nervous system
resolves10.1016/S0165-0173(01)00102-3
Molecular and cellular permeability control at the blood–brain barrier
resolves10.1002/glia.1104
Glial cell influence on the human blood‐brain barrier
resolves10.1016/S0165-5728(98)00145-3
A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation
resolves10.1111/j.1750-3639.1996.tb00855.x
Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways
resolves10.1016/0022-510X(95)00209-K
The microglial cell. A historical review
resolves10.1016/S0167-5699(99)01512-1
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes
resolves10.1002/(SICI)1098-1136(20000215)29:4<293::AID-GLIA1>3.0.CO;2-A
Brain-immune connection: Immuno-regulatory properties of CNS-resident cells
resolves10.1093/oxfordjournals.jbchem.a002969
Microglia: Activation and Their Significance in the Central Nervous System
resolves10.1097/00005072-199405000-00001
Astrocyte Responses to CNS Injury
resolves10.1002/glia.1107
Immune function of astrocytes
resolves10.1093/intimm/11.7.1169
Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production
resolves10.1016/S0165-5728(99)00215-5
Role of astrocytes in antigen presentation and naive T-cell activation
resolves10.1016/S0165-5728(00)00327-1
Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis
resolves10.1002/glia.1105
Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system
resolves10.1016/S1359-6101(97)00018-X
TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases
resolves10.1006/clin.1997.4409
TGF-β: A Critical Modulator of Immune Cell Function
resolves10.1016/S1043-2760(01)00547-1
New clues about vitamin D functions in the nervous system
resolves10.1016/0142-9612(96)85754-1
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers
resolves10.1016/S0939-6411(97)00065-9
Pharmacological modulation of the tissue response to implanted polylactic-co-glycolic acid microspheres
resolves10.1097/00006123-199612000-00023
Efficacy of Intralesionaliy Administered Cisplatin-impregnated Biodegradable Polymer for the Treatment of 9L Gliosarcoma in the Rat
resolves10.1002/jbm.10019
Uptake of poly(<scp>D,L</scp>‐lactic‐<i>co</i>‐glycolic acid) microspheres by antigen‐presenting cells <i>in vivo</i>
resolves10.1038/32588
Dendritic cells and the control of immunity
resolves10.1182/blood.V90.9.3245
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
resolves10.3109/10611860009009208
Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery Vehicle
resolves10.1016/0168-3659(95)00163-8
Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks
resolves10.1016/S0939-6411(96)00006-9
Biocompatibility of ABA triblock copolymer microparticles consisting of poly(l-lactic-co-glycolic-acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection
resolves10.1016/S0168-3659(98)00030-3
Plasma protein adsorption on biodegradable microspheres consisting of poly(d,l-lactide-co-glycolide), poly(l-lactide) or ABA triblock copolymers containing poly(oxyethylene)
resolves10.1002/(SICI)1097-4636(199601)30:1<31::AID-JBM5>3.0.CO;2-S
In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks
resolves10.1016/S0168-3659(98)00093-5
Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models
resolves10.1016/0272-0590(89)90258-3
The cage implant system for determining in vivo biocompatibility of medical device materials*1
resolves10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H
Biocompatibility of a biodegradablein situ forming implant system in rhesus monkeys
resolves10.1002/jbm.820290612
Biological performance of a degradable poly(lactic acid‐ε‐caprolactone) nerve guide: Influence of tube dimensions
resolves10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.0.CO;2-F
Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-?-caprolactone)
resolves10.1016/S0198-8859(96)00288-1
Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity
resolves10.1016/S0065-2776(08)60930-X
Immunologically Privileged Sites
resolves10.1016/S0167-5699(97)81663-5
The role of FasL-induced apoptosis in immune privilege
resolves10.4049/jimmunol.158.8.3557
Immune deviation in relation to ocular immune privilege
resolves10.1084/jem.190.9.1197
Immune Privilege
resolves10.1016/0169-409X(95)00018-3
Delivery systems for intraocular routes
resolves10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
resolves10.1016/S0079-6700(97)00048-8
Biodegradable polymers for the controlled release of ocular drugs
resolves10.1016/S0169-409X(01)00192-2
Biodegradable scleral plugs for vitreoretinal drug delivery
resolves10.1076/ceyr.16.7.633.5063
Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits
resolves10.1076/ceyr.16.9.930.5042
Biodegradable scleral implant for intravitreal controlled release of fluconazole
resolves10.1016/S0939-6411(00)00090-4
Hydrogels in pharmaceutical formulations
resolves10.1016/S0142-9612(96)00085-3
In vivo tissue compatibility of two radio-opaque polymeric biomaterials
resolves10.1038/nbt0298-172
Sustained local drug delivery from a radiopaque implanted reservoir
resolves10.1111/j.1749-6632.1997.tb52184.x
HPMA‐based Biodegradable Hydrogels Containing Different Forms of Doxorubicin Antitumor Effects and Biocompatibility<sup>a</sup>
resolves10.1016/S0142-9612(97)00242-1
Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: Human serum proteins in vitro and rat proteins following implantation
resolves10.1016/S0168-3659(99)00234-5
Making microencapsulation work: conformal coating, immobilization gels and in vivo performance
resolves10.1016/S0142-9612(97)00221-4
Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery
resolves10.1016/S0142-9612(98)00019-2
Poly(anhydride-co-imides): in vivo biocompatibility in a rat model
resolves10.1002/(SICI)1097-4628(19990411)72:2<227::AID-APP8>3.0.CO;2-Z
Copolymerization and polymer blending of trimethylene carbonate and adipic anhydride for tailored drug delivery
resolves10.1016/S0142-9612(99)00268-9
Sterilization, storage stability and in vivo biocompatibility of poly(trimethylene carbonate)/poly(adipic anhydride) blends
resolves10.1016/S0939-6411(00)00085-0
Poly(ortho esters) – their development and some recent applications
resolves10.1016/S0168-3659(97)00050-3
New generation of poly(ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibility
resolves10.1016/S0169-409X(01)00220-4
Therapeutic applications of viscous and injectable poly(ortho esters)
resolves10.1016/S0168-3659(99)00218-7
Development of a poly(ortho ester) prototype with a latent acid in the polymer backbone for 5-fluorouracil delivery
resolves10.1002/(SICI)1097-4636(199802)39:2<277::AID-JBM15>3.0.CO;2-A
Subconjunctival biocompatibility of a viscous bioerodable poly(ortho ester)
resolves10.1016/S0142-9612(00)00065-X
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation
resolves10.1016/S0939-6411(00)00107-7
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release
resolves10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application
resolves10.1016/0142-9612(95)93851-4
Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis
resolves10.1177/088391159701200101
Peripheral Nerve Reconstruction with Bioabsorbable Polyphosphazene Conduits
resolves10.1016/S0010-7824(01)00285-2
Toxicology of polymers for implant contraceptives for women
resolves10.3109/10717549709051884
Adsorption of Brain Proteins on the Surface of Poly (D,L-lactide-co-glycolide) (PLGA) Microspheres
resolves10.1016/S0165-5728(99)00203-9
Immune defects observed in patients with primary malignant brain tumors
resolves10.3171/jns.2001.95.6.1012
Site-specific immune response to implanted gliomas
resolves10.3109/10717549709052017
Carboplatin-Loaded PLGA Microspheres for Intracerebral Implantation: In Vivo Characterization
resolves10.3109/10717549809031385
<b>Direct Intracerebral Delivery of Carboplatin from PLGA Microspheres Against Experimental Malignant Glioma in Rats</b>
resolves10.1016/S0168-3659(96)01477-0
Bioerosion and biocompatibility of poly(d,l-lactic-co-glycolic acid) implants in brain
resolves10.1007/BF00689766
Histopathological evaluation of materials implanted in the cerebral cortex
resolves10.1177/096368979900800114
Biocompatibility of Poly (DL-Lactide-co-Glycolide) Microspheres Implanted into the Brain
resolves10.1016/0142-9612(93)90151-Q
Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres
resolves10.3171/jns.2001.95.3.0489
Analysis of brain biocompatibility of drug-releasing biodegradable microspheres by scanning and transmission electron microscopy
resolves10.1016/S0142-9612(00)00141-1
Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons
resolves10.1006/exnr.1999.7253
Intracerebral Implantation of NGF-Releasing Biodegradable Microspheres Protects Striatum against Excitotoxic Damage
resolves10.1016/S0304-3940(01)02534-4
The fate of biodegradable microspheres injected into rat brain
resolves10.1002/bit.260441007
Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400‐μm polyacrylate microcapsules by submerged nozzle–liquid jet extrusion
resolves10.1016/S0142-9612(97)00241-X
HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis
resolves10.1177/096368979900800413
Evaluation of Reaction of Primate Brain to Grafted PC12 Cells
resolves10.1021/bp000113m
Biocompatibility of HEMA Copolymers Designed for Treatment of CNS Diseases with Polymer-Encapsulated Cells
resolves10.1023/A:1011297828955
Biological properties of copolymer of 2-Hydroxyethyl methacrylate with sulfopropyl methacrylate
resolves10.1111/j.1749-6632.1997.tb52187.x
Anionic Polymers for Implantation
resolves10.1023/A:1018534111419
Comparative study of human monocyte and platelet adhesion to hydrogels in vitro – effect of polymer structure
resolves10.1089/sct.1989.5.55
Biocompatibility of a Biodegradable, Controlled-Release Polymer in the Rabbit Brain
resolves10.1002/jbm.820230209
Brain biocompatibility of a biodegradable, controlled‐release polymer in rats
resolves10.1016/0168-3659(92)90087-8
Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid
resolves10.1016/0267-6605(93)90104-F
Ocular and brain biocompatibility of polymeric delivery materials prepared from ester derivatives of hyaluronic acid
resolves10.3171/jns.1994.80.2.0283
Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain
resolves10.1006/exnr.1996.0055
Histological Analysis of Microencapsulated Dopamine-Secreting Cells in Agarose/Poly(styrene sulfonic acid) Mixed Gel Xenotransplanted into the Brain
The 13 references without a DOI — listed, not checked
no DOI — not checkedThe biocompatibility and toxicity of degradable polymeric materials
no DOI — not checked10.1016/S0142-9612(03)00161-3_BIB5
no DOI — not checkedDefinitions in biomaterials
no DOI — not checkedCollagen sponge implants—applications, characteristics and evaluation
no DOI — not checkedProtein delivery by microencapsulated cells
no DOI — not checkedDunn RL, English JP, Cowsar DR, Vanderbilt D. Biodegradable in situ forming implants and methods of producing the same. US Patent No. 4,938,763, 1990.
no DOI — not checkedAcrylic polymers
no DOI — not checkedThe biocompatibility of poly(anhydride-co-imides)
no DOI — not checkedEvaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye
no DOI — not checkedVeronese. Bioabsorbable polyphosphazene matrices as systems for calcitonin controlled release
no DOI — not checkedCalcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation
no DOI — not checkedPhenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors
no DOI — not checkedDistribution and tolerance of biodegradable PLAGA microspheres implanted in the rabbit lumbar subarachnoid space
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/s0142-9612(03)00161-3"><img src="https://citestamp.com/citestamped/10.1016/s0142-9612(03)00161-3/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/s0142-9612(03)00161-3/badge.svg)](https://citestamp.com/citestamped/10.1016/s0142-9612(03)00161-3)